Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast

Pathology

Volumn 37, Issue 2, 2005, Pages 131-136

  Son, B H ^a   Choi, J S ^b   Lee, J H ^b,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Breast cancer; DNA ploidy; KAI1; Survivin

Indexed keywords

CD82 ANTIGEN; PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; CANCER STAGING; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; WESTERN BLOTTING;

EID: 17844402730     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500058144     Document Type: Article

References (20)

1. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001; 19: 1688-97.
2. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998; 352: 930-42.
3. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene during the progression of human prostatic cancer on human chromosome 11p11.2. Science 1995; 268: 884-6.
4. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 1998; 153: 973-83.
5. Adachi M, Taki T, Ieki Y, et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996; 56: 1751-5.
6. Guo X, Friess H, Graber HU, et al. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996; 56: 4876-80.
7. Yu Y, Yang JL, Markovic B, et al. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997; 3: 1045-9.
8. Hinoda Y, Adachi Y, Takaoka A, et al. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Lett 1998; 129: 229-34.
9. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-21.
10. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58: 1808-12.
11. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998; 58: 5071-4.
12. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152: 43-9.
13. Bloom HJG, Richardson WW. Histological grading and prognostic in breast cancer: a study of 1409 cases of which 359 followed for 15 years. Br J Cancer 1957; 11: 359-77.
14. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.
15. Hemler ME, Mannion BA, Berditchevski F. Association of tm4sf proteins with integrins: relevance to cancer. Biochim Biophys Acta 1996; 1287: 67-71.
16. Yang XH, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997; 119: 149-55.
17. Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M. KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res 2000; 6: 3424-9.
18. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46-54.
19. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000; 6: 127-34.
20. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer 2003; 88: 1077-83.